Olema Pharmaceuticals (OLMA) Earnings Date & Reports
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
OLMA is expected to report earnings to rise 48.61% to -53 cents per share on August 12
Q2'25
Est.
$-0.54
Q1'25
Beat
by $0.18
Q4'24
Beat
by $0.13
Q3'24
Missed
by $0.03
Q2'24
Est.
$-0.54
The last earnings report on May 13 showed earnings per share of -36 cents, beating the estimate of -54 cents. With 848.50K shares outstanding, the current market capitalization sits at 287.71M.